*Escherichia coli* colonizes most neonates within hours of birth, likely during delivery (Bettelheim *et al.* [@bib3]). *Escherichia coli* is notoriously dual natured. Most strains coexist with their host without incident, while others are highly pathogenic. The difference in the ability of strains to cause disease resides in specific genes encoding virulence factors, the acquisition of which often depends on horizontal transfer. The core genome shared among all *E. coli* strains amounts to only ∼40% of its average 5000 gene total, while the total number of genes that exist in all *E. coli* strains is predicted to exceed 15 000 (Rasko *et al.* [@bib21]; Touchon *et al.* [@bib29]). While the nomenclature of *E. coli* remains in a state of flux as our understanding evolves, a variety of pathotypes have been described (Kaper, Nataro and Mobley [@bib19]; Croxen *et al.* [@bib8]).

*Escherichia coli* can cause disease at many sites outside the gastrointestinal tract, including the urinary tract, meninges, biliary tract, peritoneum, lungs, and skin and soft tissue (Russo and Johnson [@bib25]). Strains that cause these infections often share several known and suspected virulence factors, and thus have been grouped into a single pathotype called extraintestinal pathogenic *E. coli* (ExPEC) (Russo and Johnson [@bib24]). The known and suspected virulence factors common among ExPEC, whether from urinary tract infections (UTIs) or other sites, include capsule, iron-uptake systems and a variety of pili, most notably P fimbriae (Russo and Johnson [@bib24]). Serotyping, randomly amplified polymorphic DNA genomic profiling, multilocus sequence typing and pulsed field gel electrophoresis reveal that closely related strains from the same lineage can cause UTIs and infections at other sites (Johnson and Russo [@bib16]; Johnson *et al.* [@bib17]), providing the rationale that ExPEC is an appropriate category.

Strains typically associated with diarrheal illness include enteropathogenic (EPEC), enterohemorrhagic (EHEC), enterotoxigenic (ETEC), enteroaggregative (EAEC) and enteroinvasive *E. coli* (EIEC) (Kaper, Nataro and Mobley [@bib19]; Croxen *et al.* [@bib8]). The clinical syndrome caused by infection varies among these organisms, but diarrhea is the predominant symptom. Very rarely, isolates from *E. coli* pathotypes typically associated with enteric infections have caused infections outside the gastrointestinal tract. For example, case reports of UTIs due to diffuse-adhering *E. coli*, Shiga-toxin-producing *E. coli* (STEC) and EAEC have been reported (Tarr *et al.* [@bib28]; Germani *et al.* [@bib12]; Olesen *et al.* [@bib20]). Bacteremia secondary to such strains is even less common, with only a few such reports in the literature. Recently, Herzog *et al.* ([@bib14]) reported a case of an EAEC strain causing UTI and bacteremia in a renal transplant patient on immunosuppressive therapy. There has also been a report of EIEC bacteremia, in a patient with AIDS (Bessesen *et al.* [@bib2]). Here we report the draft genome sequence of a strain that caused bacteremia in an adult with severe diarrhea.

A 55-year-old man with well-controlled HIV was admitted to the Veterans Affairs Maryland Health Care System in Baltimore, Maryland, with a 3-week history of progressive diarrhea and cramping abdominal pain. By the time of presentation, he was having 10--15 watery, non-bloody bowel movements per day. The pain was diffuse throughout the abdomen. He denied nausea, vomiting, subjective fever and chills.

His HIV had been treated for the past six years with atazanavir and lopinavir/ritonavir, with an undetectable viral load and recent CD4 count of 271 mm^−3^. He had chronic hepatitis C infection. He was a current tobacco user and had a remote history of cocaine use.

His vital signs and oxygen saturation were normal. Orthostatic blood pressure and pulse were not recorded. He was cachectic and ill appearing with dry mucous membranes. His abdomen was soft, but tender in all quadrants. His peripheral white blood cell count was elevated (Table S1, Supporting Information) with 91% neutrophils and 2% band forms. He was anemic and had hyponatremia (120 mEq/L) and acute kidney injury. His liver function parameters were also abnormal with marked hyperbilirubinemia.

Computed tomography scan without intravenous contrast revealed non-specific gallbladder wall thickening and mild ascites. Magnetic resonance cholangiopancreatography showed no abnormality of the biliary tree. Later in his hospitalization, he also underwent liver biopsy, which revealed moderate to marked activity with early cirrhosis (modified Batts--Ludwig Classification: Grade 3--4, Stage 3--4) in addition to marked chronic cholestasis.

Fecal *Clostridium difficile* toxin gene PCR was negative. Fecal tests for leukocytes and ova and parasites were also negative. Stool culture revealed heavy growth of an oxidase-negative, non-lactose fermenting Gram-negative bacillus, but tests for *Salmonella, Shigella, Yersinia, Campylobacter, Aeromonas, Plesiomonas* and *Vibrio* species were negative and the isolate was discarded.

At presentation, he received multiple liters of intravenous fluid and his antiretroviral medication was held in consideration of his hepatic insult. Blood cultures drawn in the emergency department grew a non-lactose fermenting Gram-negative rod. A suspected diagnosis of *Salmonella* bacteremia was excluded when biochemical testing of the blood isolate indicated *E. coli* (API^®^ 20E code 5144502 Biomerieux, Hazelwood, MO). Although the strain did not ferment lactose, it converted tryptophan to indole and displayed lysine decarboxylase activity.

Antibiotic therapy with piperacillin-tazobactam was initiated on admission. Based on sensitivities of the blood isolate, antibiotic coverage was narrowed to ciprofloxacin. The patient\'s diarrhea resolved, his metabolic parameters began to return to baseline and his antiretroviral medications were resumed. He was discharged 7 days after his presentation to finish a 2-week course of oral ciprofloxacin. On follow-up 1 month later, he felt well, his liver enzymes and total bilirubin were normal. His creatinine had improved, but remained elevated.

In view of the patient\'s bacteremia, we tested the ability of the strain isolated from blood (VACI-14) to invade epithelial cells using a standard gentamicin protection assay (Donnenberg, Donohue-Rolfe and Keusch [@bib10]). As controls, we included a human commensal isolate and an EIEC isolate (Donnenberg, Donohue-Rolfe and Keusch [@bib10]). We detected minimal invasive ability in the VACI-14 isolate compared to the EIEC strain (Fig. S1, Supporting Information).

To gain further insight into the apparent ability of the blood isolate to cause both severe diarrhea and bacteremia, we determined its draft genome sequence. Genomic DNA was extracted from the isolate using the Sigma GenElute genomic kit (Sigma-Aldrich) and sequenced using Illumina MiSeq sequencing of a paired-end library at the University of Maryland School of Medicine, Institute for Genome Sciences, Genome Resource Center with standard operating procedures (<http://www.igs.umaryland.edu/resources/grc/>). The paired-end Illumina reads were subsampled to an approximate genome coverage of 120-fold, and the subsampled reads were assembled using MaSuRCA v.1.9.2 (Zimin *et al.* [@bib32]). The assembly statistics are as follows: total number of contigs, 109; number of bases in assembly, 5241 165; average contig length, 48 084; N50, 232 331 bp; 97.07% of the bases in assembly are included in contigs \>10 kb. Overall, the draft assembly quality is excellent for these types of comparative analyses. The resulting assembly was compared to representative genomes from each of the pathotypes and phylogenetic lineages of *E. coli* and *Shigella* species. A total of 41 genomes were aligned with Mugsy (Angiuoli and Salzberg [@bib1]). Homologous blocks present in each genome were concatenated with the bx-python toolkit (<https://bitbucket.org/james_taylor/bx-python>); the total amount of conserved sequence in the core genome was ∼2.5 Mb. Columns that contained one or more gaps in the alignment were removed with Mothur (Schloss *et al.* [@bib26]), and a maximum-likelihood tree was inferred with RAxML v.7.2.8 (Stamatakis [@bib27]); bootstrap support values were calculated with 100 replicates. The resulting phylogeny was visualized with FigTree v.1.4.2 (<http://tree.bio.ed.ac.uk/software/figtree/>) (Fig. [1](#fig1){ref-type="fig"}). The genomic sequence of this isolate has been deposited in GenBank under accession number LASE00000000.

![Phylogenomic analysis of 41 *E. coli* and *Shigella* genomes that represent members of each of the sequenced pathotypes and phylogenetic groups. All genomes were aligned using Mugsy (Angiuoli and Salzberg [@bib1]) and homologous blocks were concatenated as previously described (Hazen *et al.* [@bib13]). A phylogenetic tree was inferred with RAxML v7.2.8 (Stamatakis [@bib27]) on this alignment, with 100 bootstrap replicates and nodes that have bootstrap support ≥80 are indicated by a shaded circle. Letters at nodes indicate the *E. coli* phylogroup as previously defined by MLST or phylogenomic analyses. Isolates indicated in red are from urinary tract sources of isolation.](ftv076fig1){#fig1}

Analysis of seven standard genes indicates that this strain belongs to multilocus sequence type 12 (<https://cge.cbs.dtu.dk/services/MLST/>). Phylogenetic analysis based on conservation of core *E. coli* genome revealed that the strain belongs to a lineage that includes other members of the ExPEC pathotype (highlighted in red and indicated by an asterisk in Fig. [1](#fig1){ref-type="fig"}). Indeed, features characteristic of ExPEC, including complete sets of genes for P fimbriae and hemolysin and the *kpsM* gene used to identify group II capsule loci (Johnson and O\'Bryan [@bib15]), were present (Table [1](#tbl1){ref-type="table"}). The predicted serotype of the strain, as inferred *in silico* from the sequence (<https://cge.cbs.dtu.dk/services/SerotypeFinder/>), is O4:H1. Sur-prisingly, the results of this analysis also revealed that the isolate has features defining EPEC strains, including the presence of locus of enterocyte effacement (LEE) genes encoding the ability to produce the attaching and effacing (A/E) phenotype and the absence of *stx1* and *stx2* genes encoding Shiga toxins, which are found in addition to the LEE in EHEC strains (Kaper [@bib18]). However, some essential LEE genes were not identified and the others displayed low degrees of sequence similarity, raising doubt as to whether the T3SS is fully functional in this isolate. Interestingly, genes distantly related to some *bfp* genes encoding the bundle-forming pilus (BFP) were also present. Additional common ExPEC and tEPEC virulence factors such as other iron acquisition systems and non-LEE-encoded effectors were not found in the VACI-14 strain.

###### 

Potential virulence features identified in VACI-14.

  Gene^1^   Associated pathotype   Protein                                               peptide Identity (%)^2^   BLAST e-value^3^   Reference Protein ID
  --------- ---------------------- ----------------------------------------------------- ------------------------- ------------------ ----------------------
  *hlyC*    ExPEC                  hemolysin-activating lysine-acyltransferase           100                       2E-99              AAS93636.1
  *hlyA*    ExPEC                  Hemolysin, chromosomal                                100                       0                  WP_001620144.1
  *hlyB*    ExPEC                  Alpha-hemolysin translocation ATP-binding protein     100                       0                  KGM64139.1
  *hlyD*    ExPEC                  Hemolysin secretion protein D, chromosomal            69                        0                  WP_000860472.1
  *kpsM*    ExPEC                  KpsM                                                  97                        3E-169             AAN82146.1
  *kpsT*    ExPEC                  KpsT                                                  90                        2E-124             AAN82145.1
  *papH*    ExPEC                  PAP fimbrial minor pilin protein                      100                       2E-108             KEN78663.1
  *papC*    ExPEC                  Outer membrane usher protein papC                     99                        0                  CAM84417.1
  *papD*    ExPEC                  Chaperone protein papD                                99                        1E-176             WP_001758925.1
  *papK*    ExPEC                  Fimbrial adapter papK                                 87                        1E-13              ENB84384.1
  *papK*    ExPEC                  Fimbrial adapter papK                                 100                       9E-45              WP_029404503.1
  *papE*    ExPEC                  Fimbrial protein papE                                 100                       5E-124             WP_001621802.1
  *papF*    ExPEC                  Minor pilin subunit PapF                              100                       5E-124             WP_001621802.1
  *papK*    ExPEC                  Fimbrial adapter papK                                 100                       2E-41              WP_029404503.1
  *papK*    ExPEC                  Fimbrial adapter papK                                 87                        1E-13              ENB84384.1
  *papD*    ExPEC                  Chaperone protein papD                                100                       5E-178             WP_000265729.1
  *papC*    ExPEC                  Outer membrane usher protein papC                     100                       0                  EOV01938.1
  *papH*    ExPEC                  PAP fimbrial minor pilin protein                      98                        1E-138             KEN81350.1
  *prsA*    ExPEC                  PRS fimbrial major pilin protein                      100                       4E-121             EFJ72838.1
  --        ExPEC                  TonB-dependent siderophore receptor                   99                        0                  WP_021542660.1
  *flu*     ExPEC                  Antigen-43                                            100                       0                  WP_021517784.1
  *flu*     ExPEC                  Antigen-43                                            100                       0                  EQN15149.1
  --        ExPEC                  Yersiniabactin biosynthetic protein                   99                        0                  WP_021521384.1
  *tia*     ETEC                   Tia adhesin                                           99                        8E-179             EFJ81905.1
  *sen*     EIEC                   shET2 enterotoxin, N-terminal region family protein   99                        2E-112             CDL47274.1
  *espF*    EPEC, EHEC             LEE-encoded effector EspF                             46                        \>1                YP_002331392.1
  --        EPEC, EHEC             Component of T3SS                                     27                        \>1                YP_002331393.1
  *escF*    EPEC, EHEC             T3SS structure protein EscF                           34                        0.7                YP_002331394.1
            EPEC, EHEC                                                                   35                        0.21               
  *espB*    EPEC, EHEC             Translocon EspB                                       NSM                       NSM                YP_002331396.1
  *espD*    EPEC, EHEC             Translocon EspD                                       35                        0.15               YP_002331397.1
  *espA*    EPEC, EHEC             Translocon EspA                                       NSM                       NSM                YP_002331398.1
  *speL*    EPEC, EHEC             Secretion switching protein SpeL                      NSM                       NSM                YP_002331399.1
  *escD*    EPEC, EHEC             T3SS structure protein EscD                           31                        \>1                YP_002331400.1
  *eae*     EPEC, EHEC             Intimin                                               41                        7E-96              YP_002331401.1
  *cesT*    EPEC, EHEC             Chaperone CesT                                        29                        0.25               YP_002331402.1
  *tir*     EPEC, EHEC             Translocated intimin receptor Tir                     36                        \>1                YP_002331403.1
  *map*     EPEC, EHEC             LEE-encoded effector Map                              26                        0.16               YP_002331404.1
  *cesF*    EPEC, EHEC             Chaperone CesF                                        29                        \>1                YP_002331405.1
  *espH*    EPEC, EHEC             LEE-encoded effector EspH                             29                        0.51               YP_002331406.1
  *sepQ*    EPEC, EHEC             T3SS structure protein SepQ                           35                        2.2                YP_002331407.1
  --        EPEC, EHEC             Hypothetical protein                                  28                        0.14               YP_002331408.1
  --        EPEC, EHEC             Hypothetical protein                                  28                        \>1                YP_002331409.1
  *escN*    EPEC, EHEC             Translocator EscN                                     40                        1E-79              YP_002331410.1
  *escV*    EPEC, EHEC             Translocator EscV                                     33                        5E-84              YP_002331411.1
  *mpc*     EPEC, EHEC             Regulator Mpc                                         32                        \>1                YP_002331412.1
  *espZ*    EPEC, EHEC             LEE-encoded effector EspZ                             32                        0.68               YP_002331413.1
  *rorf8*   EPEC, EHEC             Chaperone of T3SS Rorf8                               24                        \>1                YP_002331414.1
  *escJ*    EPEC, EHEC             T3SS structure protein EscJ                           26                        0.38               YP_002331415.1
  *sepD*    EPEC, EHEC             Secretion switching protein SepD                      29                        \>1                YP_002331416.1
  *escC*    EPEC, EHEC             T3SS structure protein EscC                           29                        4E-20              YP_002331417.1
  *cesD*    EPEC, EHEC             Chaperone CesD                                        44                        0.007              YP_002331418.1
  *grlA*    EPEC, EHEC             Positive regulator GrlA                               29                        0.008              YP_002331419.1
  *grlR*    EPEC, EHEC             Negative regulator GrlR                               56                        \>1                YP_002331420.1
  --        EPEC, EHEC             Hypothetical protein                                  39                        6E-28              YP_002331421.1
  *escU*    EPEC, EHEC             Secretion system apparatus protein SsaU               26                        3E-30              YP_002331422.1
  *escT*    EPEC, EHEC             T3SS structure protein EscT                           31                        0.69               YP_002331423.1
  *escS*    EPEC, EHEC             T3SS structure protein EscS                           38                        0.006              YP_002331424.1
  *escR*    EPEC, EHEC             Type III secretion system protein                     40                        3E-35              YP_002331425.1
  --        EPEC, EHEC             Component of T3SS                                     39                        \>1                YP_002331426.1
  --        EPEC, EHEC             Component of T3SS                                     45                        \>1                YP_002331427.1
  --        EPEC, EHEC             Component of T3SS                                     50                        \>1                YP_002331428.1
  --        EPEC, EHEC             Component of T3SS                                     35                        0.19               YP_002331429.1
  *ler*     EPEC, EHEC             Transcriptional regulator Ler                         44                        0.004              YP_002331430.1
  --        EPEC, EHEC             Hypothetical protein                                  39                        \>1                YP_002331431.1
  *espG*    EPEC, EHEC             LEE-encoded effector EspG                             NSM                       NSM                YP_002331432.1
  *bfpA*    EPEC                   Bundlin                                               NSM                       NSM                NSM
  *bfpG*    EPEC                   BfpG                                                  NSM                       NSM                NSM
  *bfpB*    EPEC                   BfpB                                                  26                        2E-34              NP_053067.1
  *bfpC*    EPEC                   BfpC                                                  NSM                       NSM                NSM
  *bfpU*    EPEC                   BfpU                                                  NSM                       NSM                NSM
  *bfpD*    EPEC                   BfpD                                                  31                        3E-49              NP_053070.1
  *bfpE*    EPEC                   BfpE                                                  30                        3E-31              NP_053071.1
  *bfpF*    EPEC                   BfpF                                                  32                        7E-21              NP_053072.1
  *bfpP*    EPEC                   Prepilin peptidase                                    28                        1E-19              NP_053073.1
  *bfpH*    EPEC                   BfpH                                                  28                        6E-07              NP_053074.1
  *bfpI*    EPEC                   BfpI                                                  NSM                       NSM                NSM
  *bfpJ*    EPEC                   BfpJ                                                  NSM                       NSM                NSM
  *bfpK*    EPEC                   BfpK                                                  NSM                       NSM                NSM
  *bfpL*    EPEC                   BfpL                                                  NSM                       NSM                NSM
  *perA*    EPEC                   PerA                                                  37                        3E-18              NP_053086.1
  *perB*    EPEC                   PerB                                                  NSM                       NSM                NSM
  *perC*    EPEC                   PerC                                                  NSM                       NSM                NSM

^1^"--" indicates that there is no meaningful gene name or that the gene has more than one name.

^2^NSM -- no significant match.

^3^The BLAST analysis is based on the TBLASTN algorithm.

A/E activity and localized adherence are defining phenotypes of typical EPEC strains (Kaper [@bib18]). However, as the patient\'s isolate rapidly destroyed the tissue culture cells used in these assays (not shown), we were unable to test for either of these phenotypes. Strains that produce BFP also often exhibit autoaggregation when grown under conditions that induce BFP expression (Bieber *et al.* [@bib4]). We observed such aggregates after incubation for three hours at 37°C in Dulbecco\'s Modified Eagle Medium, although they were smaller than those produced by the prototype EPEC strain, E2348/69 (Fig. S2, Supporting Information).

Here, we report the unique case of a patient with severe, protracted diarrhea and multiorgan dysfunction with bacteremia due to an ExPEC strain that also featured distant orthologs of genes characteristic of EPEC. We presume that the non-lactose-fermenting Gram-negative rod that dominated his stool culture was the same strain, although this cannot be confirmed. While chronic diarrhea is a well-described complication of EPEC infection (Rothbaum *et al.* [@bib23]), the disease occurs almost exclusively in infants and bacteremia is exceptional. We attribute the unusual presentation of chronic diarrhea and bacteremia due to *E. coli* to a combination of host and bacterial factors.

The patient\'s immunocompromised status, as evidenced by his low CD4 count, cachexia and cirrhosis, likely played a role in his severe illness. CD4^−/−^ mice infected with *Citrobacter rodentium*, which shares the A/E genes and phenotype with EPEC, suffer rapid mortality and splenic and hepatic abscesses, indicating systemic spread of the bacteria (Bry and Brenner [@bib6]). In animal models, protein malnutrition can facilitate translocation of bacteria across the intestinal mucosa (Deitch *et al.* [@bib9]). Cirrhosis, a well-recognized risk factor for numerous serious infections, contributes to poor pathogen clearance by a variety of mechanisms (Christou, Pappas and Falagas [@bib7]).

We believe that the patient\'s acute kidney injury and hyponatremia were due to volume loss secondary to his severe and prolonged diarrhea. Similarly, it is possible that his liver derangements were also secondary to prolonged hypovolemia, exacerbated by chronic hepatitis C-associated liver disease and cirrhosis. However, cholestasis associated with bacteremia may have contributed to the clinical presentation.

The genomic sequence of this patient\'s isolate reveals features characteristic of both ExPEC and EPEC. The core genome of this isolate is most similar to other ExPEC isolates associated with urinary tract and other systemic infections. Indeed, this isolate had many features associated with ExPEC including capsule and iron-acquisition systems likely to have facilitated its survival in the blood. How it crossed from the intestinal lumen into the bloodstream is unclear. The fact that we did not observe evidence of cellular invasion is difficult to interpret, as we later observed that it caused extensive damage to tissue culture cells. This rapid cell destruction may be due to *E. coli* hemolysin, which could facilitate breach of the epithelial barrier (Trifillis *et al.* [@bib31]). In contrast to the core genome sequence, the accessory genome of the patient\'s isolate includes highly divergent versions of genes found in EPEC and additional genes found in other diarrheagenic *E. coli*. These findings highlight the dynamic nature of these pathogens.

As noted above, hybrid strains of *E. coli* have been reported previously. Most notably, a 2011 outbreak in Germany due to a hybrid STEC-EAEC sickened 3816 people with 54 deaths (Frank *et al.* [@bib11]). Genomic comparison with previously cultured isolates indicated that the outbreak was caused by a hybrid EAEC strain that developed increased potential for systemic illness following acquisition of the bacteriophage encoding Shiga toxin 2 (Rasko *et al.* [@bib22]).

Previously, a patient with severe diarrhea and bacteremia due to what would now be called an atypical (*bfp-*) EPEC strain was described (Bratoeva *et al.* [@bib5]). Although it produced uncharacterized pili, the presence of *pap* genes encoding P-fimbriae or other features characteristic of ExPEC was not reported. Genes characteristic of intestinal pathogenic *E. coli* have previously been noted among strains isolated from patients with UTIs (Toval *et al.* [@bib30]). As revealed by its phylogenetic history, the strain described in the current report may have evolved from an ExPEC strain already capable of causing systemic infection, by the acquisition of mobile genetic elements distantly related to those encoding BFP and A/E ability, as has been described more generally in EPEC (Hazen *et al.* [@bib13]). Indeed, EPEC strains closely related to ExPEC have been described previously (Hazen *et al.* [@bib13]). However, characteristic ExPEC virulence genes are not present in those strains (data not shown). While bacteremia due to a hybrid ExPEC-EPEC strain appears to be rare, the total burden of such complex *E. coli* strains on human health remains to be determined.

Supplementary Material
======================

###### Supplementary data are available at FEMSPD online

The authors are grateful to Ms. Marianne Norfolk, MT (ASCP) for expert assistance in diagnostic microbiology.

SUPPLEMENTARY DATA {#sec1}
==================

[Supplementary data are available at FEMSPD online](http://femspd.oxfordjournals.org/lookup/suppl/doi:10.1093/femspd/ftv076/-/DC1).

FUNDING {#sec2}
=======

This work was supported by Public Health Service grants U19 AI090873 and U19 AI110820 from the National Institute of Allergy and Infectious Diseases.

 {#sec3}

***Conflict of interest.*** None declared.
